Desipramine, sold under the brand name Norpramin among others, is a tricyclic antidepressant (TCA) used in the treatment of depression. It acts as a relatively selective norepinephrine reuptake inhibitor, though it does also have other activities such as weak serotonin reuptake inhibitory, α1-blocking, antihistamine, and anticholinergic effects. The drug is not considered a first-line treatment for depression since the introduction of selective serotonin reuptake inhibitor (SSRI) antidepressants, which have fewer side effects and are safer in overdose.
Pagoclone is an anxiolytic agent from the cyclopyrrolone family, related to better-known drugs such as the sleeping medication zopiclone. It was synthesized by a French team working for Rhone-Poulenc & Rorer S.A. Pagoclone belongs to the class of nonbenzodiazepines, which have similar effects to the older benzodiazepine group, but with quite different chemical structures. It was never commercialised.
The Journal of Sex & Marital Therapy is a peer-reviewed scientific journal published by Routledge and formerly by Brunner/Mazel. Its editor-in-chief is R. Taylor Segraves.
Pipamperone, also known as carpiperone and floropipamide or fluoropipamide, and as floropipamide hydrochloride (JAN), is a typical antipsychotic of the butyrophenone family used in the treatment of schizophrenia and as a sleep aid for depression. It is or has been marketed under brand names including Dipiperon, Dipiperal, Piperonil, Piperonyl, and Propitan. Pipamperone was discovered at Janssen Pharmaceutica in 1961, and entered clinical trials in the United States in 1963.
DailyMed is a website operated by the U.S. National Library of Medicine (NLM) to publish up-to-date and accurate drug labels to health care providers and the general public. The contents of DailyMed is provided and updated daily by the U.S. Food and Drug Administration (FDA). The FDA in turn collects this information from the pharmaceutical industry.
The Journal of Consulting and Clinical Psychology is a monthly academic journal published by the American Psychological Association. Its focus is on treatment and prevention in all areas of clinical and clinical-health psychology and especially on topics that appeal to a broad clinical-scientist and practitioner audience. The editor-in-chief is Joanne Davila.
Barry John Everitt, is a British neuroscientist and academic. He was Master of Downing College, Cambridge (2003–2013), and Professor of Behavioural Neuroscience at the University of Cambridge (1997–2013). He is now emeritus professor and Director of Research. From 2013 to 2022, he was provost of the Gates Cambridge Trust at Cambridge University.
Trevor William RobbinsCBE FRS FMedSci is a professor of cognitive neuroscience and the former Head of the Department of Psychology at the University of Cambridge. Robbins interests are in the fields of cognitive neuroscience, behavioural neuroscience and psychopharmacology.
Timiperone, sold under the brand name Tolopelon, is a typical antipsychotic of the butyrophenone class which is marketed in Japan for the treatment of schizophrenia. It is similar in chemical structure to benperidol, but has a thiourea group instead of a urea group. It acts as an antagonist for the D2 and 5-HT2A receptors.
Cianopramine (INN), also known as 3-cyanoimipramine, is a tricyclic antidepressant related to imipramine that acts as a serotonin reuptake inhibitor and weak serotonin receptor antagonist. It was investigated for the treatment of depression but was never marketed.
Moperone (Luvatren, since discontinued) is a typical antipsychotic of the butyrophenone class which is marketed in Japan for the treatment of schizophrenia. It is an antagonist for the D2 (Ki 0.7–1.9 nM), D3 (Ki 0.1–1 nM), and 5-HT2A (Ki 52 nM) receptors. It also has a high binding affinity for the sigma receptors.
The Journal of Psychopharmacology is a monthly peer-reviewed scientific journal published by SAGE Publications on behalf of the British Association for Psychopharmacology. It was established in 1987 and is a member of the Committee on Publication Ethics. The editors-in-chief are David Nutt and Pierre Blier. The journal covers all aspects of psychopharmacology.
Tedatioxetine is an experimental antidepressant that was discovered by scientists at Lundbeck; in 2007 Lundbeck and Takeda entered into a partnership that included tedatioxetine but was focused on another, more advanced Lundbeck drug candidate, vortioxetine.
The Journal of Clinical Psychopharmacology is a peer-reviewed medical journal published by Lippincott Williams & Wilkins covering clinical psychopharmacology. It was founded by Richard I. Shader, MD in 1981 as the first journal of an international scope devoted solely to clinical psychopharmacology. David J. Greenblatt, MD served as Co-Editor-In-Chief. Drs. Shader and Greenblatt remained at the helm of the journal until both retired at the end of 2020. Anthony J. Rothschild, MD became JCP's new Editor-in-Chief in January 2021.
The International Journal of Neuropsychopharmacology is a peer-reviewed scientific journal published by Oxford University Press. It is an official journal of the Collegium Internationale Neuro-Psychopharmacologicum (CINP) and covers basic and clinical topics in neuropharmacology and psychopharmacology. It was established in 1998 by Bernard Lerer, who served as editor-in-chief until 2008.
Barbara Jacquelyn Sahakian, is professor of clinical neuropsychology at the department of psychiatry and Medical Research Council (MRC)/Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge. She is also an honorary clinical psychologist at Addenbrooke's Hospital, Cambridge. She has an international reputation in the fields of cognitive psychopharmacology, neuroethics, neuropsychology, neuropsychiatry and neuroimaging.
Experimental and Clinical Psychopharmacology is a peer-reviewed scientific journal published by the American Psychological Association. It was established in 1993 and covers research in clinical psychology. The current editor-in-chief is William W. Stoops.
Progress in Neuro-Psychopharmacology & Biological Psychiatry is a peer-reviewed academic journal publishing review articles and original research reports pertaining to neuropsychopharmacology and biological psychiatry.
International Clinical Psychopharmacology is a bimonthly peer-reviewed medical journal published by Wolters Kluwer Health. It covers neuropsychopharmacology and clinical psychiatry. It was established in 1986. The editor-in-chief is Alessandro Serretti.
The Journal of Child and Adolescent Psychopharmacology is a peer-reviewed medical journal covering psychopharmacology in children and adolescents. It was established in 1990 and is published ten times per year by Mary Ann Liebert. The editor-in-chief is Harold S. Koplewicz. According to the Journal Citation Reports, the journal has a 2017 impact factor of 2.901.
